| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | -$227K | -120.5% |
| R&D Expense | $44.4M | +25.3% |
| SG&A Expense | $14.7M | +8.8% |
| Operating Income | -$59.3M | -24.0% |
| Pre-tax Income | -$59.2M | -24.0% |
| Income Tax | $6K | +73.5% |
| Net Income | -$59.2M | -24.0% |
| EPS (Basic) | -$8.51 | -3304.0% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.6M | -75.6% |
| Current Assets | $17.5M | -75.3% |
| Total Assets | $21.1M | -71.7% |
| Current Liabilities | $4.6M | -20.8% |
| Total Liabilities | $9.0M | -9.3% |
| Stockholders' Equity | $12.1M | -81.3% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.7M | -9.9% |
| Investing Cash Flow | -$740K | -269.4% |
| Financing Cash Flow | -$1.0M | -109.9% |